Quick answer
Buy KPV for research on the strength of its paperwork: a named HPLC method, mass-spectrometry identity, a lot-specific certificate, and clear separation of standalone KPV from the GHK-KPV hybrid.
- Molecule: Lys-Pro-Val, the C-terminal tripeptide of α-MSH, about 342 Da
- Size problem: three residues are easy to make and easy to mislabel; identity needs mass spectrometry, not only HPLC
- Look-alike: GHK-KPV is a different compound with a different mass; the listing must say which one is in the vial
- V8 listings: KPV research vial (5 mg) and GHK-KPV research vial (60 mg blend), both ≥98% HPLC purity specification
- Planning: stock math (mg ÷ mL) in the reconstitution calculator
Research Use Only. For laboratory research use only; not for human consumption.
What KPV is and why sourcing it is its own problem
KPV is a short synthetic tripeptide (Lysine-Proline-Valine) corresponding to the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH). It is studied in laboratory settings for anti-inflammatory and mucosal-signaling mechanisms, with the literature reporting activity that does not depend on classical melanocortin-receptor activation; the details are in the KPV research overview and the introduction to KPV. The relationship to its parent hormone is compared in KPV vs. alpha-MSH.
Because the sequence is so short, sourcing is less about a synthesis quirk and more about fundamentals: verified purity, confirmed identity, and batch-level documentation a lab can cite. The paradox of tiny peptides is that they are cheap and simple to produce, which also makes it simple to produce something poorly and label it confidently.
| Property | KPV |
|---|---|
| Sequence | Lys-Pro-Val |
| Approximate molecular weight | About 342 Da |
| Origin | C-terminal fragment of α-MSH |
| Supplied form | Lyophilized powder |
| V8 vial size | 5 mg |
Minimum specifications to look for
- Purity ≥98% by HPLC: the analytical method should be named on the certificate of analysis, not just a number printed on a label. See HPLC purity analysis.
- Identity confirmed by mass spectrometry: a three-residue sequence is easy to synthesize and easy to mislabel; the measured mass is what verifies that the molecule in the vial matches the stated sequence. See HPLC vs. mass spectrometry.
- Batch-specific certificate of analysis: tied to the exact lot shipped, not a template reused across runs. See how to read a CoA.
- Net peptide content disclosed: the labeled vial mass includes counter-ions and residual moisture in addition to peptide.
- Lyophilized form with storage guidance: a stable dry powder with clear storage direction. See storing research peptides.
Why a tripeptide is harder to verify than it looks
A very small peptide poses specific analytical challenges. KPV is polar and elutes early from a standard C18 column, near the solvent front, so a method that is not tuned for small polar analytes can hide impurities under the void peak. Weak UV absorbance (there are no aromatic residues; only the peptide bonds absorb, near 214 nm) means that small impurities and inorganic salts are poorly represented in an area-percent figure. Typical related substances include the dipeptides Lys-Pro and Pro-Val from incomplete coupling, and diketopiperazine formation, a known side reaction at Pro-containing dipeptide stages of solid-phase synthesis.
Mass spectrometry addresses the identity side directly: a [M+H]+ ion near m/z 343 for KPV is easily distinguished from the dipeptides and from the much heavier GHK-containing hybrid. Low-mass peptides sit in a noisy region of the spectrum where solvent clusters and matrix ions can interfere, so a clean, labeled spectrum matters more here than for a large peptide.
KPV vs. GHK-KPV: know which one you are sourcing
KPV is sold both as the standalone tripeptide and combined with the copper-binding tripeptide GHK in the hybrid GHK-KPV. These are chemically distinct research materials with different molecular weights and different literature behind them, and a listing should make unambiguous which one is in the vial instead of using the names interchangeably. If a listing is vague about the sequence being sold, that is a documentation gap, not a minor detail. For buying guidance on the hybrid, see where to buy GHK-KPV, and for its testing see GHK-KPV purity testing.
| Listing says | What it should document |
|---|---|
| KPV | Sequence Lys-Pro-Val; mass near 342 Da; vial mass of a single peptide |
| GHK-KPV | The combined sequence and its own mass; how the components are defined; separate documentation from standalone KPV |
| A blend that includes KPV | Component list with each component reported on the certificate, not just a total |
Evaluating a supplier
A practical framework for vetting any KPV supplier comes down to a handful of direct questions:
- Is the certificate issued per batch, or is the same document reused across production runs?
- Was testing performed in-house, by an independent laboratory, or both? See third-party testing explained.
- Does the listing clearly distinguish standalone KPV from GHK-KPV, with separate documentation for each?
- Are the terms of sale explicitly research-use-only?
- Does the vial size and labeled mass match what is described on both the product page and the certificate?
Suppliers with nothing to hide answer these plainly and can produce documentation on request. Vague answers or a refusal to provide a batch-specific certificate are reasons to look elsewhere. The longer checklists are in choosing a peptide supplier and red flags when buying research peptides.
Purity versus content, and what it does to stock concentration
Purity says how much of the detected peptide is KPV; content says how much of the powder is peptide. For a tripeptide with two basic sites (the lysine side chain and the N-terminus), counter-ion mass can be a large fraction of the dry weight, because each basic site can carry an acetate or trifluoroacetate. That makes the gap between labeled mass and net peptide larger for KPV than for a long peptide with proportionally fewer ionizable sites. Stock concentration is simply mg divided by mL, so an overstated mass passes straight through to the concentration. The peptide calculator and the reconstitution calculator guide cover the arithmetic.
Price as a signal, not just a cost
KPV pricing dramatically below the market range for HPLC-verified, mass-spec-confirmed, batch-documented material deserves investigation rather than celebration. Analytical testing, proper Fmoc solid-phase synthesis and careful handling all cost money; a price that leaves no room for them usually means a step was skipped. Compare cost per milligram of documented peptide, not cost per vial.
Quantity, consistency and shipping
Labs running ongoing KPV work should plan around consistent batch sourcing rather than one-off purchases from different suppliers. Even legitimate batch-to-batch variation exists, and mixing sources mid-study makes it harder to control. Record lot numbers in the lab notebook for every experiment. Shipping should suit a lyophilized peptide reagent: tracked domestic shipping reduces transit time and handling uncertainty compared with international orders that may sit in customs.
Where to buy documented KPV
V8 Peptides lists KPV as a 5 mg lyophilized powder with a ≥98% HPLC purity specification, on the KPV research vial page, and the hybrid as a 60 mg blend on the GHK-KPV research vial page. Both pages list batch documentation items such as compound identity, measured HPLC purity, lot number and test date, and lot reports are published through the CoA library as they become available; if a lot's report is not yet posted, ask before ordering. The pages state refrigerated storage at 2–8 °C, with −20 °C for long-term holds, and USPS shipping.
Frequently asked questions
What purity should I expect from research KPV?
A stated HPLC purity, commonly ≥98%, with the method named on a lot-specific certificate. Because a tripeptide elutes early and absorbs weakly, the method details matter more than for a larger peptide.
Why is mass spectrometry needed for a tripeptide?
HPLC shows how clean a sample is, not what it is. KPV is about 342 Da, so its identity is confirmed by a mass near that value, which also separates it from dipeptide impurities and from the larger GHK-KPV hybrid.
Is KPV the same as GHK-KPV?
No. GHK-KPV combines the GHK copper-binding tripeptide with KPV into a different compound with a different mass and separate literature. A listing should state clearly which one is being sold.
Does a 5 mg vial contain 5 mg of KPV?
Not exactly. The labeled mass is the gross powder weight, including counter-ions and residual moisture. Net peptide content is lower, so calculated concentrations are nominal unless net content is stated.
What impurities are typical for a short peptide like KPV?
Dipeptide deletion products (Lys-Pro, Pro-Val), diketopiperazine by-products from the Pro-containing stage, and residual salts. Only some of these are visible by UV area percent.
How should I store KPV?
The V8 product page lists refrigeration at 2–8 °C, or −20 °C for long-term storage, protected from heat, moisture and light.
Is a low price a concern?
It can be. Testing, purification and handling carry real cost, so a price that leaves no room for them is a reason to request documentation before buying.
Where do I find documentation for a V8 KPV lot?
In the CoA library and the batch-documentation section of the product page. Ask before ordering if a lot's report is not yet posted.
Research Use Only. For laboratory research use only; not for human consumption. Supplied strictly for laboratory research and development. This article is research education, not usage guidance.
References
- V8 Peptides. KPV research overview.
- V8 Peptides. KPV vs. alpha-MSH melanocortin comparison.
- V8 Peptides. Understanding HPLC purity.
- V8 Peptides. HPLC vs. mass spectrometry.
- V8 Peptides. How to read a CoA.
- V8 Peptides. KPV research vial.
